+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ziprasidone"

From
Mental Illness Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Mental Illness Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 92 Pages
  • China
From
Geodon - Product Thumbnail Image

Geodon

  • Report
  • April 2018
  • 20 Pages
  • Global
From
Mental Illness Drugs Markets in China - Product Thumbnail Image

Mental Illness Drugs Markets in China

  • Report
  • November 2023
  • 251 Pages
  • China
From
From
Schizophrenia Market Report and Forecast 2024-2032 - Product Thumbnail Image

Schizophrenia Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 160 Pages
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Ziprasidone is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and depression. It is a second-generation antipsychotic drug, which means it is more effective and has fewer side effects than first-generation antipsychotics. Ziprasidone works by blocking certain receptors in the brain, which helps to reduce symptoms of mental illness. It is available in both oral and injectable forms. Ziprasidone is a popular choice for treating mental disorders due to its effectiveness and low risk of side effects. It is also relatively affordable, making it a viable option for many patients. Additionally, it has been approved for use in children and adolescents, making it a viable option for treating mental illness in this population. The Ziprasidone market is highly competitive, with many companies offering the drug. Some of the major players in the market include Pfizer, Sun Pharmaceuticals, Mylan, and Teva Pharmaceuticals. Show Less Read more